← Back to all trials
Recruiting
NCT05633472
The Roles of Vitamin D and Microbiome in Children With Post-acute COVID-19 Syndromes (PACS) and Long COVID
Conditions: Post-acute COVID-19 Syndromes
Sex: All
Ages: 0 Years – 18 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 150
Sponsor: China Medical University Hospital
Location: Taiwan
Summary
A double-blind study to evaluate the role of human microbiome and vitamin D in the development of long COVID and PACS in children.
Eligibility Criteria
Inclusion Criteria:Children aged 0-18 yearsThe child sought/needed primary or secondary medical care for COVID-19Laboratory (RT-PCR, COVID-19 antigen tests or SARS-CoV-2 antibody testing) or physician confirmed SARS-CoV-2 infection based on classic clinical symptoms and/or ground-glass opacification on CT imaging.28 days - 3 months from the onset of COVID-19 symptomsParent's/carer's/guardians consent to participateExclusion Criteria:Recruit patients who have used antibiotics, systemic steroids, and immunosuppressants in the previous month.Patients with C1 esterase inhibitor deficiency, lymphocytopenia, thrombocytopenia, severe diseases involving heart, liver, or kidney, metabolic disease, or autoimmune disease.
Source: ClinicalTrials.gov (NCT05633472). StuddyBuddy aggregates publicly available trial information.
